z-logo
open-access-imgOpen Access
Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3
Author(s) -
Nicole Mollé,
Spencer Krichevsky,
Pouneh Kermani,
Richard T. Silver,
Ellen K. Ritchie,
Joseph M. Scandura
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2019003050
Subject(s) - ruxolitinib , blocking (statistics) , leptin , signal transduction , medicine , pharmacology , biology , myelofibrosis , obesity , microbiology and biotechnology , computer science , bone marrow , computer network

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom